Albert Ludolph

789 total citations
3 papers, 119 citations indexed

About

Albert Ludolph is a scholar working on Neurology, Genetics and Sociology and Political Science. According to data from OpenAlex, Albert Ludolph has authored 3 papers receiving a total of 119 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Neurology, 2 papers in Genetics and 1 paper in Sociology and Political Science. Recurrent topics in Albert Ludolph's work include Amyotrophic Lateral Sclerosis Research (3 papers), Neurogenetic and Muscular Disorders Research (2 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). Albert Ludolph is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (3 papers), Neurogenetic and Muscular Disorders Research (2 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). Albert Ludolph collaborates with scholars based in Germany, United Kingdom and Netherlands. Albert Ludolph's co-authors include Dorothée Lulé, Andrea Kübler, Niels Birbaumer, James Mather, Stacy A. Rudnicki, Michael Bozik, Hiroshi Mitsumoto, Leonard H. van den Berg, Benjamin Rix Brooks and Bing Zhang and has published in prestigious journals such as Journal of Neurology Neurosurgery & Psychiatry, Deutsches Ärzteblatt international and Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.

In The Last Decade

Albert Ludolph

3 papers receiving 115 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Albert Ludolph Germany	3	97	48	23	17	15	3	119
Bertram Walter Germany	5	47 0.5×	26 0.5×	17 0.7×	14 0.8×	5 0.3×	11	98
Daichi Yokoi Japan	5	103 1.1×	54 1.1×	23 1.0×	5 0.3×	10 0.7×	5	121
Saman Heshmat Australia	4	179 1.8×	112 2.3×	34 1.5×	33 1.9×	18 1.2×	9	218
Paolo Volanti Italy	6	274 2.8×	167 3.5×	45 2.0×	13 0.8×	21 1.4×	10	322
Alessio Maranzano Italy	10	173 1.8×	57 1.2×	33 1.4×	6 0.4×	38 2.5×	28	212
Stephanie Scala United States	6	124 1.3×	30 0.6×	14 0.6×	4 0.2×	17 1.1×	6	151
Sarah Ahmed United States	4	55 0.6×	31 0.6×	33 1.4×	6 0.4×	14 0.9×	7	107
Philippe Couratier France	5	75 0.8×	36 0.8×	42 1.8×	13 0.8×	8 0.5×	5	150
E Costantino France	4	75 0.8×	22 0.5×	7 0.3×	3 0.2×	7 0.5×	8	104
Michael Wheaton United States	5	284 2.9×	142 3.0×	33 1.4×	19 1.1×	17 1.1×	5	326

Countries citing papers authored by Albert Ludolph

Since Specialization

Citations

This map shows the geographic impact of Albert Ludolph's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Ludolph with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Ludolph more than expected).

Fields of papers citing papers by Albert Ludolph

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Ludolph. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Ludolph. The network helps show where Albert Ludolph may publish in the future.

Co-authorship network of co-authors of Albert Ludolph

This figure shows the co-authorship network connecting the top 25 collaborators of Albert Ludolph. A scholar is included among the top collaborators of Albert Ludolph based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Ludolph. Albert Ludolph is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

3 of 3 papers shown

1.

Al‐Chalabi, Ammar, Pamela J. Shaw, P. Nigel Leigh, et al.. (2019). Oral levosimendan in amyotrophic lateral sclerosis: a phase II multicentre, randomised, double-blind, placebo-controlled trial. Journal of Neurology Neurosurgery & Psychiatry. 90(10). 1165–1170. 14 indexed citations

2.

Bozik, Michael, Hiroshi Mitsumoto, Benjamin Rix Brooks, et al.. (2014). A post hoc analysis of subgroup outcomes and creatinine in the phase III clinical trial (EMPOWER) of dexpramipexole in ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 15(5-6). 406–413. 39 indexed citations

3.

Lulé, Dorothée, et al.. (2008). Depression and Quality of Life in Patients With Amyotrophic Lateral Sclerosis. Deutsches Ärzteblatt international. 105(23). 397–403. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact